+ All Categories
Home > Documents > TRANSFER TO PHARMA INDUSTRY - Aetionomy · New applications for knowledge mining, data analysis,...

TRANSFER TO PHARMA INDUSTRY - Aetionomy · New applications for knowledge mining, data analysis,...

Date post: 27-Jun-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
1
New applications for knowledge mining, data analysis, disease modelling and virtualization Multimodal Mechanistic Signatures Database for Neurodegenerative Diseases NeuroMMSig: a collection of candidate mechanisms represented as computable networks Machine Learning – Predictive Modeling and Bayesian Networks Predictive disease risk models using multi-scale clinical data and longitudinal disease progression Bayesian representations of clinical studies representing feature dependencies Simulation of Patients – Virtual Patient Cohorts Generating huge virtual patient cohorts for research overcoming legal / ethical barriers Building a platform for in silico testing and validation of candidate mechanisms Virtualizing incomplete patient data and generating missing data TRANSFER TO PHARMA INDUSTRY Generating a mechanism-based taxonomy of Alzheimer‘s and Parkinson‘s disease and validating in the course of a prospective clinical trial www.aetionomy .eu N O MY The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under AETIONOMY grant agreement n°115568, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. www.imi.europa.eu
Transcript
Page 1: TRANSFER TO PHARMA INDUSTRY - Aetionomy · New applications for knowledge mining, data analysis, disease modelling and virtualization Multimodal Mechanistic Signatures Database for

New applications for knowledge mining, data analysis, disease modelling and virtualization

Multimodal Mechanistic Signatures Database for Neurodegenerative Diseases• NeuroMMSig: a collection of

candidate mechanisms represented as computable networks

Machine Learning – Predictive Modeling and Bayesian Networks • Predictive disease risk models using

multi-scale clinical data and longitudinal disease progression

• Bayesian representations of clinical studies representing feature dependencies

Simulation of Patients – Virtual Patient Cohorts• Generating huge virtual patient cohorts

for research overcoming legal / ethical barriers

• Building a platform for in silico testing and validation of candidate mechanisms

• Virtualizing incomplete patient data and generating missing data

TRANSFER TO PHARMA INDUSTRY

Generating a mechanism-based taxonomy of Alzheimer‘s and Parkinson‘s disease and validating in the course of a prospective clinical trial

www.aetionomy.eu

N OM Y

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under AETIONOMY grant agreement n°115568, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

www.imi.europa.eu

Recommended